Page 190 - PRECONGRESS COURSE 06

Supplementation of luteal phase with hCG after GnRH agonist triggering in high risk for OHSS patients
Conclusions
In high risk for OHSS patients triggered by GnRH agonist the administration of hCG for luteal phase support can lead to the development of severe OHSS Incidence: 4%
95% CI: 0 to 9
Supplementation of luteal phase with hCG after GnRH agonist triggering
Conclusions
Following GnRH agonist triggering in low risk for OHSS patients, administration of hCG in single dose is not likely to result in severe OHSS
This is not, however, the case when hCG is administered in two doses of 1500 IU in low risk patients
Following GnRH agonist triggering in high risk for severe OHSS patients, administration of hCG in either single or multiple doses
can lead to the development of severe OHSS in~ 4% of cases
190
Page 186 of 258